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Abstract 
Oral‑facial‑digital syndromes (OFDS) represent a heterogeneous group of rare developmental disorders affecting the 
mouth, the face and the digits. Additional signs may involve brain, kidneys and other organs thus better defining the 
different clinical subtypes. With the exception of OFD types I and VIII, which are X‑linked, the majority of OFDS is trans‑
mitted as an autosomal recessive syndrome. A number of genes have already found to be mutated in OFDS and most 
of the encoded proteins are predicted or proven to be involved in primary cilia/basal body function. Preliminary data 
indicate a physical interaction among some of those proteins and future studies will clarify whether all OFDS proteins 
are part of a network functionally connected to cilia. Mutations in some of the genes can also lead to other types of 
ciliopathies with partially overlapping phenotypes, such as Joubert syndrome (JS) and Meckel syndrome (MKS), sup‑
porting the concept that cilia‑related diseases might be a continuous spectrum of the same phenotype with different 
degrees of severity. To date, seven of the described OFDS still await a molecular definition and two unclassified forms 
need further clinical and molecular validation. Next‑generation sequencing (NGS) approaches are expected to shed 
light on how many OFDS geneticists should consider while evaluating oral‑facial‑digital cases. Functional studies will 
establish whether the non‑ciliary functions of the transcripts mutated in OFDS might contribute to any of the pheno‑
typic abnormalities observed in OFDS.
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Background
The oral-facial-digital syndromes (OFDS) represent a 
group of rare developmental disorders characterized by 
abnormalities of the face, oral cavity and digits. Addi-
tional signs involving the central nervous system (CNS), 
and visceral organs, such as the kidney, are also fre-
quently observed. The first case presenting this condi-
tion was reported in 1941 [1] and since then a number 
of different OFDS types with overlapping phenotypes 
have been described [2, 3] (Table 1). Among the different 
types, OFD type I is the most frequently observed and 
can be easily recognized by its typical X-linked dominant 
male-lethal pattern of inheritance in familial cases. Most 
of the other OFDS are transmitted as autosomal recessive 
syndromes or represent sporadic cases. In the last few 
years, 11 genes responsible for OFDS have been identi-
fied allowing a better clinical and genetic definition for 
this heterogeneous condition. This review will focus on 
the most recent findings on OFDI, III, IV, VI, IX, XIV and 
two unclassified OFD subtypes. For all other OFDS please 
refer to [3]. On the basis of the recent molecular data, we 
can distinguish (1) two more common types (OFDI and 
OFDVI), for which the causative genes have been identi-
fied; (2) four rare subtypes for which the causative gene 
has also been identified (OFDIII, OFDIV, OFDIX and 
OFDXIV), thus allowing molecular diagnosis; (3) two 
unclassified rare OFD subtypes whose causative genes 
have been identified but that still require further clini-
cal and molecular validation and (4) additional unclassi-
fied OFDS which still await molecular characterization 
and further definition (Table 1). Table 2 reports a clinical 
summary of the different OFDS clearly identified to date.
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OFD type I syndrome (OFDI)
OFDI was described in 1954 [4] and further defined in 
1962 [5]. It has an estimated incidence of 1:50,000 live 
births [6] and it has been reported in different ethnic 
backgrounds with no evidence of founder effect. It is 
transmitted as an X-linked dominant condition with male 
lethality, which usually occurs during the first and second 
trimester of pregnancy [7–9]. Only a small percentage 
of cases display familiar inheritance and the majority of 
mutations are sporadic (~75 %). The clinical spectrum of 
the disease includes craniofacial, oral and skeletal abnor-
malities in >80 % of cases (see [7] for details). Renal cystic 
disease is commonly observed as well as involvement of 
the CNS, which includes brain developmental anoma-
lies and cognitive defects [10, 11]. Additional findings 
may include pancreatic, hepatic, and/or ovarian cysts 
and hearing defects [7, 12]. The gene responsible for 
OFD type I syndrome was identified on the short arm of 
the X chromosome [13]. Different mutations have been 
reported to date, including frameshifts, which represent 
the majority of mutations (>60  %), splicing, missense, 
nonsense and genomic rearrangements [7, 10, 11]. Addi-
tional file  1: Table S1 summarizes the mutations identi-
fied to date. The responsible gene, initially known as 
CXORF5 and subsequently named OFD1, encodes for the 
centrosomal/basal body OFD1 protein [14, 15] required 
for left–right axis specification and for primary cilia 
formation [16–21]. OFD type I is a male-lethal disor-
der and male cases with OFD1 mutations associated to 
a classical OFDI phenotype have never been described. 
Interestingly, three affected males with “unclassified” 
X-linked lethal congenital malformation syndrome and a 
splice mutation in the OFD1 gene have been described. 
The mother was mildly affected and presented only few 
accessory oral frenulae and irregular teeth [22]. OFD1 
mutations have also been reported in males in X-linked 
recessive conditions, namely (1) a mental retardation 
syndrome comprising macrocephaly and ciliary dysfunc-
tion [23] mapping to the same locus as Simpson–Golabi–
Behemel syndrome type 2 (SGBS2); (2) Joubert syndrome 
(JS) patients (JBT10) [24–26] and (3) retinitis pigmentosa 
(RP23) [27]. These findings suggest that mutations in the 
Table 1 Classified OFDS
* References for disease gene identification and/or review discussing the main features of the disease
OFD subtypes MIM# Altern SYMB Aliases Gene REF*/Notes
OFDI 311200 OFDSI; OFD1 Orofaciodigital type I; Oral‑facial‑digital type I; 
Papillon‑Leage/Psaume syndrome
OFD1 [7, 13]
OFDII 252100 OFDSII; OFD2 Orofaciodigital type II; Oral‑facial‑digital type II; Mohr 
syndrome
– [3]
OFDIII 258850 OFDSIII; OFD3 Orofaciodigital type III; Oral‑facial‑digital type III: 
Sugarman syndrome
TMEM231 [29]
OFD IV 258860 OFDSIV; OFD4 Orofaciodigital type IV; Oral‑facial‑digital type IV; 
Mohr‑Majewski Baraitser syndrome
TCTN3 [32]
OFDV 174300 OFDSV; OFD5 Orofaciodigital type V; Oral‑facial‑digital type V 
Thurston syndrome
– [3] /Indian origin
OFDVI 277170 OFDSVI; OFD6 Orofaciodigital type VI; Oral‑facial‑digital type VI 
Varadi syndrome
TMEM216 OFD1, C5ORF42 
TMEM107
[24, 34–37]
OFDVII 608518 OFDSVII; OFD7 Orofaciodigital type VII; Oral‑facial‑digital type VII [3]
OFDVIII 300484 OFDSVIII; OFD8 Orofaciodigital type VIII;
Oral‑facial‑digital type VIII; Edwards syndrome
– [3]
OFDIX 258865 OFDSIX; OFD9 Orofaciodigital type IX;
Oral‑facial‑digital type IX
TBC1D32 SCLT1 [41]
OFDX OFDSX; OFD10 Orofaciodigital type X; Oral‑facial‑digital type X; 
Figuera syndrome
– [3]
OFDXI OFDXI; OFD11 Orofaciodigital type XI; Oral‑facial‑digital type XI; 
Gabrielli syndrome
– [3]
OFDXII OFDXII; OFD12 Orofaciodigital type XII; Oral‑facial‑digital type XII; 
Moran Barroso Syndrome
– [3]
OFDXIII OFD XIII; OFD13 Orofaciodigital type XIII; Oral‑facial‑digital type XIII; 
Degner syndrome
– [3]
OFDXIV 615948 OFDXIV; OFD14 Orofaciodigital type XIV; Oral‑facial‑digital type XIV; C2CD3 [43]
Unclassified OFD WDPCP [44]
Unclassified OFD DDX59 [47]
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OFD1 gene may result in a single syndrome spectrum 
characterized by wide intra- and inter-familial pheno-
typic variability possibly depending on the contribution 
of still unknown genetic modifiers.
OFD type III syndrome (OFDIII)
OFDIII was described in 1971 [28]. Affected patients 
present with orofaciodigital findings similar to those 
described in the other OFDS, involvement of the CNS 
and renal disease. The typical manifestation that is only 
seen, among OFDs, in OFDIII cases is an oculomo-
tor apraxia resulting in “metronome eye movements”. 
Recent data identified mutations in TMEM231 (Addi-
tional file  2: Table S2) in two affected OFDIII siblings 
during a targeted medical sequencing of 1056 individu-
als with nephronophthisis-related ciliopathies [29]. The 
two cases presented with the typical eye movements, lin-
gual hamartomas, postaxial polydactyly and involvement 
of the CNS (intellectual disabilities, cerebellar vermis 
hypoplasia and Dandy Walker malformation with cystic 
dilation of the 4th ventricle). Both cases were born with 
a normal renal morphology and function but developed 
end stage renal failure within the third decade of life. In 
the same report, recurrent TMEM231 mutations were 
also identified in MKS patients [29]. Functional studies 
demonstrated that TMEM231 is involved in ciliary func-
tions. Accordingly, mice with mutations in Tmem231 dis-
play a clear ciliopathy phenotype including renal cystic 
disease, malformations of the hepatic ductal plate and 
skeletal abnormalities [29].
OFD type IV syndrome (OFDIV)
This OFD subtype was originally described in a famil-
ial case in which two affected sisters displayed the typi-
cal oral-facial-digital findings in addition to severe tibial 
dysplasia [30, 31]. In 2012, a genome wide homozygo-
sity mapping approach was undertaken on a case born 
to a consanguineous family and displaying facial dys-
morphism with lobulated tongue, polydactyly of all four 
limbs, renal cystic disease, liver ductal plate prolifera-
tion, occipital encephalocele and other brain anomalies. 
X-rays examination revealed severe tibia hypoplasia and 
bowing of long bones. Targeted resequencing of candi-
date genes in homozygosity regions identified a unique 
nonsense mutation, c.1222C  >  T (p.Glu408*) in tec-
tonic-3 (TCTN3). Analysis of additional cases led to 
the identification of three TCTN3 truncating mutations 
segregating within the affected family members with 
the expected autosomal recessive inheritance pattern 
and two compound heterozygous frameshift mutations 
[32] (Additional file  2: Table S2). All affected cases pre-
sented with skeletal dysplasia with long bone bowing and 
tibia hypoplasia and only two cases displayed associated 
orofaciodigital findings. Interestingly, in the same study, 
the authors reported a TCTN3 mutation in a JS case 
(c.940G  >  A). The JS mutation involves a nucleotide 
which is not affected in OFDIV patients but additional 
studies are required to establish a clear genotype/pheno-
type correlation. On the basis of these results, the authors 
concluded that OFDIV phenotypes can include long 
bone bowing, tibia hypoplasia, cystic kidney, encepha-
locele and other brain malformations [32].
OFD type VI syndrome (OFDVI)
This form was initially described in 1980 in a Hungar-
ian isolated population presenting with oro-facio-digital 
findings associated with central and or/cerebellar anom-
alies [33]. OFD VI is characterized by the presence of a 
“so-called” molar tooth sign (MTS) on brain MRI associ-
ated to one or more of the following: (1) hamartoma(s) 
of the tongue and/or additional frenula; (2) digital abnor-
malities (e.g. mesoaxial polydactyly of one or more hands 
or feet, postaxial and preaxial polydactyly) and (3) hypo-
thalamic hamartoma. Additional oral-facial (e.g. cleft lip 
and palate) and/or digital signs may also be observed. 
The presence of the MTS allowed researchers to ascribe 
OFDVI to the group of Joubert syndrome (JS)-associated 
disorders. OFDVI differs from pure JS cases for the pres-
ence of the oral-facial-digital findings and can be defined 
as a rare phenotype of JS. Different studies analysed 
OFDVI patients and identified mutations in TMEM216, 
OFD1, C5ORF42 and TMEM107 [24, 34–37] (Additional 
file 2: Table S2). These findings highlight the clinical and 
genetic overlap among ciliopathies (see below). More 
recently, a comparison of C5ORF42 mutated versus non-
mutated OFDVI cases suggested a major role for this 
gene in limb development [38]. Interestingly, C5ORF42 
and TMEM107 were also found mutated in pure JS cases 
[38]. The causality of TMEM107 mutations in ciliopa-
thies was confirmed by independent groups [39, 40].
OFD type IX syndrome (OFDIX)
OFD type IX is characterized by retinal colobomata in 
addition to the typical oro-facio-digital findings. It is 
inherited as an autosomal recessive trait. Recently, a 
whole-exome sequencing approach identified mutations 
in TBC1D32 and SCLT1 in two patients with a severe 
ciliopathy phenotype [41]. Case 1 was born to healthy 
consanguineous parents and displayed midline defects 
including hypertelorism, midline clefts and severe cho-
anal stenosis, left hand postaxial polydactyly and eye 
abnormalities (right microphthalmia, left anophthal-
mia, bilateral optic disc coloboma). Brain malformations 
and cardiac defects were also described. Whole-exome 
sequencing identified a splicing mutation in TBC1D32 
(Additional file  2: Table S2) leading to in-frame 
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truncation of 47 amino acids. Case 2 was also born to 
healthy consanguineous parents and displayed severe 
midline cleft lip and palate, microcephaly and choanal 
atresia. He also presented severe coloboma and congeni-
tal heart disease. Brain malformations were also present 
as well as abnormal inner ear structures. In this case, 
exon sequencing revealed a splicing mutation in SCLT1 
resulting in complete skipping of exon 5 and the intro-
duction of a premature stop codon (Additional file  2: 
Table S2). Due to the presence of the eye abnormalities, 
these two cases were classified as OFDIX. TBC1D32 and 
SCLT1 have both been linked to ciliogenesis. TBC1D32 
encodes a ciliary protein predicted to contain a Tre-
2, Bub2 and Cdc16 (TBC) domain (TBC1D32). On the 
other hand, SCLT1 is an important component of the 
distal appendages, a centrosomal extension that estab-
lishes the connection between the mother centriole and 
the plasma membrane and its deficiency blocks ciliogen-
esis in the early phases of cilia formation [42].
OFD type XIV syndrome (OFDXIV)
This OFD subtype was defined after the identification 
of mutations in the C2CD3 gene. The first homozygous 
nonsense mutation (c.184C  >  T; p.Arg62*) was identi-
fied in a familial case in which the index case presented 
with classical OFD signs (lingual hamartoma, cleft and 
lobulated tongue, cleft palate, buccal frenulae, bilateral 
preaxial polydactyly of feet and postaxial polydactyly of 
hands) accompanied by microcephaly, micropenis and 
severe intellectual disabilities. Brain MRI revealed the 
presence of MTS, the cerebellar anomaly characteristic 
of JS, and other brain abnormalities (corpus callosum 
hypoplasia, subarachnoid cysts in the right occipital lobe 
and the posterior fossa, and incomplete myelination of 
the white matter). The presence of the MTS is intriguing 
and suggests a possible link with JS. His younger sister 
displayed a similar phenotype worsened by the presence 
of cardiac malformation leading to neonatal death [43]. 
An additional C2CD3 compound heterozygous muta-
tion (Additional file  2: Table S2) was identified during 
the screening of 34 OFD cases negative for mutations 
in known OFD genes in a male foetus exhibiting severe 
microcephaly, bilateral duplicated hallux and postaxial 
polydactyly, micropenis, kidney hypoplasia, corpus cal-
losum abnormalities and inferior vermian hypoplasia 
with posterior cyst [43]. On the basis of these findings 
and of the peculiar features of microcephaly and cer-
ebral malformations, this OFD subtype was classified as 
OFDXIV. Functional studies demonstrated that C2Cd3 
co-localizes and physically interacts with OFD1 and is 
involved in centriole elongation, thus defining centriole 
length regulation as an emerging pathogenetic mecha-
nism in ciliopathies [43].
Unclassified OFDS
A number of OFD subtypes still require molecular defi-
nition and characterization of OFD patients negative for 
mutations in known OFD-associated genes will lead to 
identification also of unclassified OFD subtypes. This has 
already happened in the following two examples.
Whole-exome sequencing revealed compound WDPCP 
heterozygous mutations in a female child with an unclas-
sified form of OFD [44]. This child displayed type A post-
axial polydactyly of both hands and 2/3 toe syndactyly, 
congenital heart defects and tongue hamartomas. The 
two mutations (Additional file 2: Table S2) were inherited 
from the asymptomatic father and mother. Interestingly, 
mutations in the WDPCP transcript, which regulates 
planar cell polarity and ciliogenesis [45], have also been 
reported in a patient with Bardet–Biedl syndrome (BBS) 
[46], one of the first ciliopathy characterized.
Autozygosity mapping identified a minimal interval 
on chromosome 1 in two multiplex families of Arabian 
origin displaying oral (tongue lobulation, cleft palate, 
bifid uvula), facial (frontal bossing, midline lip defects), 
digital (polydactyly) signs accompanied by additional 
abnormalities [47]. Exome sequencing analysis identi-
fied two homozygous mutations in the DDX59 transcript 
segregating with the disease in family 1 and 2 (Additional 
file 2: Table S2). DDX59 is highly enriched in the devel-
oping mouse palate and limb buds. Immunofluorescence 
analysis demonstrated a dynamic nuclear and cyto-
plasmic localization and normal ciliogenesis pattern in 
patients’ fibroblasts [47].
In both cases, future studies will clarify whether these 
conditions represent new OFD subtypes and identifica-
tion of mutations in additional patients will be necessary 
to establish these two genes as bona fide ciliopathy genes.
The link between OFDS and other ciliopathies
Mutations in ciliary genes are associated with a wide 
spectrum of clinical conditions that extends from viable 
to severe, lethal phenotypes. Oligogenic inheritance 
may explain this variability implying genetic interaction 
among different loci to cause/modulate the phenotype. 
This has already been shown for BBS, nephronophthisis 
(NPHP) and JS [48–50]. Interestingly, the unclassified 
OFD case with mutations in WDPCP also carried a dele-
terious deletion in IQCB1 which is associated to another 
ciliopathy, Senior–Loken syndrome, type 5 (SLSN5) 
characterized by early onset retinopathy and renal dis-
ease [44]. Mutations in the OFD1 gene can be associated 
to a very specific phenotype as such in X-linked recessive 
retinitis pigmentosa (RP23) or more pleiotropic disorders 
such as in X-linked dominant OFD type 1, and X-linked 
recessive Joubert syndrome (JBTS10) and a mental retar-
dation syndrome comprising macrocephaly and ciliary 
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dysfunction [23]. It will be interesting to evaluate whether 
additional mutations in other ciliary transcript may con-
tribute to the phenotypic outcome of OFD1 mutations.
The ciliopathy protein network can be divided in dis-
tinct but connected modules: the centrosome/basal 
body/pericentriolar material, the transition zone, the 
intraflagellar (IFT) complexes and the BBSome. OFDS 
genes are often mutated in other ciliopathies, especially 
Joubert and Meckel Gruber Syndromes. These conditions 
are mainly due to mutations in genes encoding proteins 
of the centrosome/basal body/pericentriolar material 
and transition zone modules (Table  3; Fig.  1) suggest-
ing that these cilia structures have a predominant role 
in the pathomechanisms underlying OFDS, JS and MKS 
syndromes.
Genes involved in OFDS: the ciliary connection
The gene responsible for OFD type I was identified in 
2001 and for a while remained the only OFD gene known. 
In the last 3–4 years, a number of genes responsible for 
other OFDS have been identified mainly through next-
generation sequencing (NGS) approaches. The majority 
of OFD genes identified localizes to cilia components 
(Fig.  1) and/or influence ciliogenesis with the exception 
of DDX59 and C5ORF52. In this section, the information 
available on link between genes mutated in OFDS and 
ciliary functions of ciliary signalling will be reviewed.
Functional studies demonstrated that OFD1 acts at 
the distal centriole to build distal appendages [18], thus 
contributing to cilia formation although in a content-spe-
cific fashion [16, 19–21]. In addition, in vivo and in vitro 
studies demonstrated that OFD1-depleted models show 
defective Shh [16, 20, 21, 51–53] and Wnt [54] signalling. 
In particular, impairment of Shh signalling from early 
stages of development may contribute to explain the skel-
etal malformations observed in OFDI patients.
TCTN3 and TMEM231 are components of a MKS 
complex localized at the transition zone of primary cilia 
and physically interact with each other. Functional stud-
ies demonstrated that they are both required for ciliogen-
esis and Shh signalling [29, 32, 55, 56].
TMEM216 localizes at the base of primary cilia and 
its loss results in defective ciliogenesis and centrosomal 
docking, with concomitant hyperactivation of RhoA and 
Dishevelled [35]. No information is available on the role 
of this transcript in Shh signalling.
TMEM107 and the planar cell polarity WDPCP pro-
teins localize both at the transition zone, contribute to 
mammalian ciliogenesis [37, 45] and are required for Shh 
signalling [45, 57].
TBC1D32 is a ciliary protein [58] although the precise 
localization within cilia is not known. Functional studies 
demonstrate that TBC1D32 controls ciliary morphology 
and is required for Shh pathway [59].
SCLT1 and C2CD3 localize at centrioles where C2CD3 
co-localizes and physically interacts with OFD1. Both 
proteins are necessary for ciliogenesis and C2CD3 is also 
required for Hedgehog signalling in mouse [42, 43, 60].
C5ORF42, also known as NKAPP1, is poorly charac-
terized and no information is available on the role of this 
transcript in cilia or cilia-mediated signalling [61].
Finally, DDX59 is a member of the DEAD-box-con-
taining RNA helicases with currently unknown function 
relating to cilia. Functional studies indicated that fibro-
blasts from affected individuals display a normal cilio-
genesis pattern in the presence of reduced Shh signalling 
[47].
The data summarized above seem to indicate a major 
role for centrosomal/centriolar function in the patho-
mechanisms underlying OFD syndrome and components 
of these cilia-related cellular compartments should be 
considered candidate genes for the unresolved OFDS. 
One of the puzzling questions in OFDS as well as in other 
ciliopathies is how much of the phenotype is due to cilia 
dysfunction and how much is due to gene functions not 
related to cilia. Shh impairment which has been dem-
onstrated in more than one OFDS and is linked to the 
ciliary function of the genes may explain the skeletal and 
some of the neurological findings observed. However, as 
we are learning by omics approaches, proteins may dis-
play different intracellular localization and functions [62, 
63]. OFD1, for example, is localized both to centrosome/
basal body and nucleus [14, 15]. Future studies will clarify 
the contribution of non-ciliary functions of OFD genes to 
the clinical spectrum of these conditions.
Table 3 The Involvement of OFDS transcripts in other cili-
opathies
a  Transcripts find mutated in different b ciliopathies
JBTS (?) No number has been assigned to this JBTS locus
SGBS2 (?) A mutation in the OFD1 gene was identified in affected members of a 
family with a X‑linked mental retardation syndrome comprising macrocephaly 
and ciliary dysfunction. This phenotype is consistent with SGBS2 mapped to the 
Xp22 region
GENEa CILIOPATHIESb
OFD1 OFDI, JBT10, RP23, SGBS2 (?)
TMEM231 OFDIII, MKS11, JBTS20
TCTN3 OFDIV, JBTS18
TMEM216 OFDVI, JBTS2, MKS2
C5ORF42 OFDVI, JBTS17
TMEM107 OFDVI, JBTS (?), MKS13
TBC1D32 OFDIX
SCLT1 OFDIX
WDCPD BBS15, OFD unclassified, BBS12, MKS6
DDX59 OFD unclassified
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Conclusions and future perspectives
A thorough clinical and molecular characterization of 
OFD patients will be critical to define how many sub-
types do really exist for this pleiotropic condition. NGS-
based approaches will define how many genes underlie 
OFDS and clinical studies will define how many dif-
ferent conditions can be clearly identified. Functional 
studies will clarify whether ciliopathies can be redefined 
not according to the genes mutated or the phenotype 
observed but according to the ciliary structural element 
functionally compromised. This knowledge may aid in 
designing the most appropriate approach to slow down 
disease progression. Finally, it is time for researchers to 
start studying and defining the non-ciliary functions of 
the transcripts mutated in OFDS (and other ciliopathies) 
to understand whether abnormal cilia can justify all the 
phenotypic abnormalities observed in OFDS.
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TBC1D32 Cilia + / +
TCTN3 Transion zone + / + 
TMEM107 Transion zone + / + 
TMEM231 Transion zone + / + 
WDPCP Transion zone + / + 
SCLT1 Distal appendages of 
centrioles
+ /NK 
OFD1 Centrosome, basal 
body, distal centriole
+ / + 
C2CD3 Distal end centrioles + / + 
TMEM216 Basal Body + / NK
DDX59 Nucleus, cytoplasm NK / + 
C5ORF42 NK NK / NK 
Fig. 1 OFDS proteins map to defined cilia compartments. Left panel, schematic representation of primary cilia. The localization of proteins encoded 
by OFDS transcripts is depicted. Right panel, the precise cilia localization is defined. The column Cilia/Shh indicate whether a ciliary localization or 
perturbation of the Shh pathway has been demonstrated (+) or not (−). NK not known
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